首页 > 市场调查报告书 > 製药

疼痛

市场调查报告书

商品编码

1548869

医用大麻市场规模、份额、成长分析：按应用程式、类型、分销管道、地区 - 产业预测，2024-2031 年

Medical Cannabis Market Size, Share, Growth Analysis, By Application (Pain Management, Others), By Type (Flower, Concentrates), By Distribution Channel (Pharmacies, Online Retailers), By Region - Industry Forecast 2024-2031

出版日期: 2024年08月27日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球医用大麻市场规模为145亿美元，从2023年的177.6亿美元成长到2031年的900.7亿美元，复合年增长率预计将成长22.50%。

各国医用大麻合法化预计将鼓励种植、减少进口并增加税收。世界各国政府都支持医用大麻的扩张。例如，2022 年 1 月，德里高等法院澄清，大麻的使用在印度基本上仍然是非法的，但允许用于医疗和科学目的。研究一致表明，医用大麻可有效治疗慢性疼痛，并且比许多替代疗法更安全。这是一种自然的解决方案，具有成本效益且副作用很少。医用大麻治疗慢性疼痛有效性的持续研究预计将对市场成长产生重大影响。例如，2022 年 5 月的一份报告发现，英国26% 的成年人患有慢性疼痛，这增加了对有效治疗方案的需求。慢性疼痛盛行率的上升促使人们对大麻作为治疗剂进行了广泛的研究。持续的研究、已证实的医疗效果、合法化和智慧财产权的进步等因素都有助于医用大麻市场的预期成长。随着这些因素的发展，可能会促进该领域的进一步扩展。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Aurora Cannabis Inc.（Canada）
Canopy Growth Corporation（Canada）
Cronos Group Inc.（Canada）
Maricann Group Inc.（Canada）
CannTrust Holdings Inc.（Canada）
Organigram Holdings Inc.（Canada）
Hexo Corp.（Canada）
Vivo Cannabis Inc.（Canada）
TerrAscend Corp.（Canada）
Curaleaf Holdings, Inc.（US）
Trulieve Cannabis Corp.（US）
Green Thumb Industries Inc.（US）
Cresco Labs Inc.（US）
Acreage Holdings, Inc.（US）
Jazz Pharmaceuticals plc（Ireland）
CV Sciences, Inc.（US）
MedMen Enterprises Inc.（US）
Khiron Life Sciences Corp.（Canada）
Aurora Cannabis Inc.（Canada）
Aleafia Health Inc.（Canada）

简介目录

Product Code: SQMIG35I2169

Global Medical Cannabis Market size was valued at USD 14.50 billion in 2022 and is poised to grow from USD 17.76 billion in 2023 to USD 90.07 billion by 2031, growing at a CAGR of 22.50% in the forecast period (2024-2031).

The legalization of medical marijuana in various countries is driving its cultivation, which is expected to reduce imports and generate tax revenue. Governments worldwide are supporting the expansion of medical cannabis. For example, in January 2022, the Delhi High Court clarified that while cannabis use remains largely illegal in India, it is allowed for medical and scientific purposes. Research has consistently shown that medical cannabis is effective in managing chronic pain and is often safer than many alternative treatments. It offers a cost-effective, natural solution with minimal side effects. Ongoing studies on the efficacy of medical marijuana for chronic pain are anticipated to significantly influence market growth. For instance, a May 2022 report noted that 26% of adults in the United Kingdom suffer from chronic pain, highlighting the increasing need for effective treatment options. The rising prevalence of chronic pain has prompted extensive research into cannabis as a treatment. Factors such as continuous research, demonstrated medical benefits, legalization, and advancements in intellectual property rights are all contributing to the expected growth of the medical cannabis market. As these elements evolve, they are likely to drive further expansion in the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medical Cannabis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Medical Cannabis Market Segmental Analysis

Global Medical Cannabis Market is segmented based on type, application and region. Based on type, the market is segmented into Flower, Concentrates [Shatters, Wax, Dabs, Oils, Other Concentrates], Others [Capsules, Topicals, Edibles & Beverages]. Based on application, market is segmented into Cancer, Pain Management [Neuropathic, Inflammatory], Neurological Health Management [Sclerosis, Epilepsy, Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Other Diseases], Mental Health Management [Post Traumatic Stress Disorder (PTSD), Depression, Anxiety, ADHD, Others], Others. Based on compound, the market is segmented into THC-Dominant, CBD-Dominant, Balanced THC & CBD. Based on distribution channel, the market is segmented into Dispensaries, Pharmacies, Online Retailers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Medical Cannabis Market

Cannabis has recently been approved for the treatment of various conditions, including nausea and vomiting induced by chemotherapy, restlessness, muscle tension, and chronic pain. Many companies are rapidly advancing their research into therapeutic cannabis and hemp. In states where cannabis is legal, edibles containing CBD and THC are becoming increasingly popular, as are infused beverages among both consumers and investors. Despite this growth, the complex regulatory process for cannabis approval may pose challenges to industry expansion. Nevertheless, the medicinal benefits of cannabis and the gradual legalization of cannabis capsules offer significant potential for market growth.

Restraints in the Global Medical Cannabis Market

Cannabis capsules are designed to provide precise and measured doses of cannabis-based medications. This controlled dosage ensures accurate administration and consistent effects, making them an appealing option for medical treatments. The potential to address various conditions, including Alzheimer's disease, cancer, epilepsy, glaucoma, PTSD, and muscle spasms, contributes to the growing global demand for these calibrated cannabis capsules. Their ability to effectively manage such diverse health issues makes them highly desirable across different regions.

Market Trends of the Global Medical Cannabis Market

The market for cannabis-based products is expanding rapidly, with a growing array of options including oils, tinctures, capsules, and topical creams. This broadening product range is driving market growth and appealing to a diverse patient base. As the variety of cannabis products increases, it attracts a broader spectrum of consumers and medical users, further fueling market expansion. The availability of different formats caters to varying patient preferences and therapeutic needs, contributing to the overall growth of the cannabis market.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive Rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors of The Market
Degree Of Competition
Top Investment Pockets
Market Attractive Index
Ecosystem Mapping
Patent Analysis
Pricing Analysis
Trade Analysis
Consumer And Buying Criteria
Regulatory Analysis
Technology Analysis
Case study Analysis

Global Medical Cannabis Market by Application

Market Overview
Cancer
Pain Management
- Neuropathic
- Inflammatory
Neurological Health Management
- Sclerosis
- Epilepsy
- Alzheimer's Disease
- Parkinson's Disease
- Huntington's Disease
- Other Diseases
Mental Health Management
- Post Traumatic Stress Disorder (PTSD)
- Depression
- Anxiety
- ADHD
- Others
Others

Global Medical Cannabis Market by Type

Market Overview
Flower
Concentrates
- Shatters
- Wax
- Dabs
- Oils
- Other Concentrates
Others
- Capsules
- Topicals
- Edibles & Beverages

Global Medical Cannabis Market by Compound

Market Overview
THC-Dominant
CBD-Dominant
Balanced THC & CBD

Global Medical Cannabis Market by Distribution Channel

Market Overview
Dispensaries
Pharmacies
Online Retailers

Global Medical Cannabis Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Aurora Cannabis Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canopy Growth Corporation (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cronos Group Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Maricann Group Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CannTrust Holdings Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Organigram Holdings Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hexo Corp. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vivo Cannabis Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TerrAscend Corp. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Curaleaf Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trulieve Cannabis Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Green Thumb Industries Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cresco Labs Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Acreage Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jazz Pharmaceuticals plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CV Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MedMen Enterprises Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Khiron Life Sciences Corp. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aurora Cannabis Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aleafia Health Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments